P53 agonists (Seattle Biomedical Research Institute/University of Washington)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameP53 agonists (Seattle Biomedical Research Institute/University of Washington)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor protein p53 stimulants
TargetsTumor protein p53
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCenter For Infectious Disease Research
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of WashingtonCenter For Infectious Disease Research
Active IndicationsN/A
Inactive IndicationsMalaria

Other Information

ATC CodeN/A
Related LinksN/A